Omigapil Publication Now Available
Long-awaited publication about the Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy now published.
Omigapil Publication Now Available
Research Update: SELENON
Interview with Gustavo Dziewczapolski: Doctor in Neuropharmacology and Scientific Director of Cure CMD
2024 Myology Congress Recap
Research Update: Collagen 6
Never Stop Driving: Cure CMD's Dedication to Community Member Simon Cantos
My Rare Advocacy Journey
2024 Rare Disease Week Recap
Uncharted Territory
Cure CMD x The Caregiver Compass Announce Partnership, Release Special Edition Caregiver Guidebook
Cure CMD Awarded 2nd MDA Advocacy Grant
10 Energy Conservation *Tips: My Workout Journey With CMD